241 related articles for article (PubMed ID: 24594114)
1. Poor CD4 recovery and risk of subsequent progression to AIDS or death despite viral suppression in a South African cohort.
Takuva S; Maskew M; Brennan AT; Long L; Sanne I; Fox MP
J Int AIDS Soc; 2014; 17(1):18651. PubMed ID: 24594114
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
[TBL] [Abstract][Full Text] [Related]
3. Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa.
McGrath N; Lessells RJ; Newell ML
HIV Med; 2015 Sep; 16(8):512-8. PubMed ID: 25959724
[TBL] [Abstract][Full Text] [Related]
4. CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
Trickey A; May MT; Schommers P; Tate J; Ingle SM; Guest JL; Gill MJ; Zangerle R; Saag M; Reiss P; Monforte AD; Johnson M; Lima VD; Sterling TR; Cavassini M; Wittkop L; Costagliola D; Sterne JAC;
Clin Infect Dis; 2017 Sep; 65(6):959-966. PubMed ID: 28903507
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
Suárez-García I; Sobrino-Vegas P; Dalmau D; Rubio R; Iribarren JA; Blanco JR; Gutierrez F; Montero Alonso M; Bernal E; Vinuesa García D; Del Amo J;
Addiction; 2016 Jul; 111(7):1235-45. PubMed ID: 26890155
[TBL] [Abstract][Full Text] [Related]
6. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
Maskew M; Fox MP; van Cutsem G; Chu K; Macphail P; Boulle A; Egger M; Africa FI
PLoS One; 2013; 8(6):e64392. PubMed ID: 23755122
[TBL] [Abstract][Full Text] [Related]
7. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
[TBL] [Abstract][Full Text] [Related]
8. HIV treatment outcomes among people with initiation CD4 counts >500 cells/µL after implementation of Treat All in South African public clinics: a retrospective cohort study.
Dorward J; Sookrajh Y; Gate K; Khubone T; Mtshaka N; Mlisana K; Ngobese H; Yende-Zuma N; Garrett N
J Int AIDS Soc; 2020 Apr; 23(4):e25479. PubMed ID: 32319203
[TBL] [Abstract][Full Text] [Related]
9. CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africa.
Hoffmann CJ; Schomaker M; Fox MP; Mutevedzi P; Giddy J; Prozesky H; Wood R; Garone DB; Egger M; Boulle A;
J Acquir Immune Defic Syndr; 2013 May; 63(1):34-41. PubMed ID: 23344547
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in mortality and CD4 count response among virally suppressed HIV-positive patients.
Maskew M; Brennan AT; Westreich D; McNamara L; MacPhail AP; Fox MP
J Womens Health (Larchmt); 2013 Feb; 22(2):113-20. PubMed ID: 23350862
[TBL] [Abstract][Full Text] [Related]
11. Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases.
Baker JV; Peng G; Rapkin J; Krason D; Reilly C; Cavert WP; Abrams DI; MacArthur RD; Henry K; Neaton JD;
J Acquir Immune Defic Syndr; 2008 Aug; 48(5):541-6. PubMed ID: 18645520
[TBL] [Abstract][Full Text] [Related]
12. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.
; Lanoy E; May M; Mocroft A; Phillip A; Justice A; Chêne G; Furrer H; Sterling T; Monforte AD; Force L; Gill J; Harris R; Hogg RS; Rockstroh J; Saag M; Khaykin P; de Wolf F; Sterne JA; Costagliola D
AIDS; 2009 Oct; 23(16):2199-208. PubMed ID: 19779320
[TBL] [Abstract][Full Text] [Related]
14. Effect of persistent moderate viremia on disease progression during HIV therapy.
Raffanti SP; Fusco JS; Sherrill BH; Hansen NI; Justice AC; D'Aquila R; Mangialardi WJ; Fusco GP;
J Acquir Immune Defic Syndr; 2004 Sep; 37(1):1147-54. PubMed ID: 15319674
[TBL] [Abstract][Full Text] [Related]
15. Population-wide differentials in HIV service access and outcomes in the Western Cape for men as compared to women, South Africa: 2008 to 2018: a cohort analysis.
Osler M; Cornell M; Ford N; Hilderbrand K; Goemaere E; Boulle A
J Int AIDS Soc; 2020 Jun; 23 Suppl 2(Suppl 2):e25530. PubMed ID: 32589367
[TBL] [Abstract][Full Text] [Related]
16. Better Virological Outcomes Among People Living With Human Immunodeficiency Virus (HIV) Initiating Early Antiretroviral Treatment (CD4 Counts ≥500 Cells/µL) in the HIV Prevention Trials Network 071 (PopART) Trial in South Africa.
Fatti G; Grimwood A; Nachega JB; Nelson JA; LaSorda K; van Zyl G; Grobbelaar N; Ayles H; Hayes R; Beyers N; Fidler S; Bock P
Clin Infect Dis; 2020 Jan; 70(3):395-403. PubMed ID: 30877753
[TBL] [Abstract][Full Text] [Related]
17. Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting.
Clouse K; Pettifor A; Maskew M; Bassett J; Van Rie A; Gay C; Behets F; Sanne I; Fox MP
AIDS; 2013 Feb; 27(4):645-50. PubMed ID: 23169326
[TBL] [Abstract][Full Text] [Related]
18. Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study.
Dorward J; Sookrajh Y; Khubone T; van der Molen J; Govender R; Phakathi S; Lewis L; Bottomley C; Maraj M; Lessells RJ; Naidoo K; Butler CC; Van Heerden R; Garrett N
Lancet HIV; 2023 May; 10(5):e284-e294. PubMed ID: 37001536
[TBL] [Abstract][Full Text] [Related]
19. Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study.
Onoya D; Sineke T; Hendrickson C; Mokhele I; Maskew M; Long LC; Fox M
BMJ Open; 2020 Mar; 10(3):e030228. PubMed ID: 32213514
[TBL] [Abstract][Full Text] [Related]
20. Higher Risks of Virologic Failure and All-Cause Deaths Among Older People Living with HIV in Chongqing, China.
Wu G; Zhou C; Zhang X; Zhang W; Lu R; Ouyang L; Xing H; Shao Y; Ruan Y; Qian HZ
AIDS Res Hum Retroviruses; 2019; 35(11-12):1095-1102. PubMed ID: 31544479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
